Voyant’s Smart Toilet Platform Addresses $13B Potential Market as it Simplifies Urine Sample Collection and Testing

Going to the doctor is not always a preferred activity, and part of that is the testing involved, including, of course, the ubiquitous urine test. This remains a standard method used to determine the proper course of treatment for patients and to prevent exposure to potentially harmful medications and procedures. Point-of-care urine tests are used to diagnose a range of conditions,

Q&A with Fletcher Wilson, Founder and CEO of InterVene

Entrepreneurship runs in Fletcher Wilson’s veins – quite literally. As founder and CEO of InterVene, a Fogarty Institute graduate that has developed a minimally invasive device for the treatment of severe venous disease in the legs, Fletcher has many of the traits that make a successful leader and innovator. That includes a penchant for identifying problems and finding solutions,

Spotlight: Eric Chehab, Ph.D., Ferolyn Fellow

Seemingly intractable issues often have simple, elegant solutions when approached with creativity. That’s what Eric Chehab, Ph.D., has found in his work designing products that solve problems in neonatal care.

As the newest addition to the Ferolyn Fellowship class, he has already attained notable accomplishments in his young career, including co-founding and spearheading Novonate.

Q&A with Mike Mussallem, Chairman and CEO of Edwards Lifesciences

Edwards Lifesciences’ first and only chairman and CEO, Mike Mussallem, is the leading force behind the company’s success and committed culture of giving back to global communities.

Widely recognized as being at the forefront of patient-focused medical innovations for structural heart disease and critical care monitoring, the company has seen its value jump 4,000 percent and employment double to more than 13,000 in the past 18 years,

Raydiant Oximetry Raises Series A Funding; Graduates from Fogarty Institute

Raydiant Oximetry, a Fogarty Institute company that is developing an innovative fetal monitor to improve outcomes for mothers and babies during childbirth, has closed a $5.6 million Series A funding round led by VCapital. It follows on the heels of a recent string of funding rounds, grants and an exit by fellow Fogarty companies Enspectra

Institute’s Partnership with the FDA Enhances Relationships On Both Sides

Since its inception four years ago, the Fogarty Institute’s FDA Fellowship program has blossomed into a successful, ongoing partnership that is being lauded on both sides for enhancing the understanding, communication and collaboration between entrepreneurs and regulators. To date, the Institute has hosted 41 Fellows in addition to FDA scientists and department heads.

The relationship has proven to be beneficial for both sides: The FDA better understands the challenges inherent in device development,

Q&A with Vincent Gaudiani, MD, Cardiac Surgeon at PCCSV

With more than 10,000 heart operations under his belt, Dr. Vincent Gaudiani is one of the most prolific practitioners in cardiovascular surgery. His early career followed a similar path as Dr. Fogarty’s, and the two later met at Stanford and have been colleagues and steadfast friends ever since.

Dr. Gaudiani received his bachelor’s degree in English from Harvard University,

START TYPING AND PRESS ENTER TO SEARCH